UBC Medical Indonesia Tbk. vs Prima Cakrawala Abadi Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Prima Cakrawala Abadi Tbk. trades at Rp38 (market cap 45.5B, 826.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 12.7× Prima Cakrawala Abadi Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 826.2K). Which is the better fit depends on your goals.
| LABS | PCAR | |
|---|---|---|
Market Cap | 576.7B | 45.5B |
Volume | 3.48M | 826.2K |
Lot | 34.82K | 8.26K |
Turnover | 522.79M | 32M |
Average Price | 150.13 | 38.73 |
Value | 522.79M | 32M |
Indicative Equilibrium Price | 148 | 38 |
Indicative Equilibrium Volume | 350 | 2.25K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →The Company was established with the name of PT Prima Abadi is a limited company that was established based on the deed of establishment Limited Company PT Prima Cakrawala Abadi No. 111 issued on January 29 2014. The Articles of Association of the company has been experiencing some changes, the updated was the Decision of the Shareholders No. 20 issued on September 19, 2017. The company started commercial business activities in the year 2014.
Read more on PCAR →